Legacy iCROs bolted on technology. GenPhase built around it — delivering a truly integrated platform.
Credentialed radiologists across a global reading network, with equivalent board certifications and unified QA protocols, not a subcontracting model. GenPhase maintains direct relationships with all readers.
Combined with US coverage, this enables true 24-hour follow-the-sun turnaround, with a cost structure that is more efficient than traditional onshore-only delivery models.
MCI-licensed radiologists credentialed to the same standards as U.S. counterparts - seamless quality parity, no compromise on clinical rigour.
Quality AssuredGenPhase directly employs and manages every radiologist. No subcontracting layers - full accountability, consistent service, and direct quality oversight.
Direct OwnershipTrue follow-the-sun coverage at a cost no pure onshore competitor can replicate without rebuilding their entire delivery model from the ground up.
Cost AdvantageONIX AI integrates with hospital PACS, eCRF systems, and third-party algorithms via standard APIs.Unlike closed platforms that can create dependency and switching costs, ONIX is designed to support flexibility and interoperability.
PACS — Imaging
Works with any imaging archive
Connects to DICOM-compliant systems from any vendor. No rip-and-replace required - your existing PACS stays in place.
eCRF — Clinical data
Plugs into any trial platform
Bidirectional sync via RESTful and HL7 FHIR endpoints with your existing clinical data capture system.
Algorithms — Models
Run any vendor algorithm
Bring third-party or proprietary models into a unified, validated imaging pipeline - side by side, without conflict.
If you already have imaging infrastructure in place, we integrate with it, not replace it.
Unlike proprietary closed platforms that create dependency and switching costs, GenPhase never locks a sponsor in. Bring your stack - we integrate with it.
GenPhase operates real clinical workflows on its own platform. Every production decision is validated against actual trial workflows from day one - not retrofitted from a staging environment.
"The platform is its own QA."
Modern oncology trials increasingly require both imaging reads (CT/MRI for RECIST) and digital pathology analysis (H&E, IHC).These capabilities are often delivered through separate vendors, adding operational complexity.
GenPhase is building toward a unified, multi-modal platform that brings radiology and pathology together under a single accountable system.
CT/MRI for RECIST compliance. Tumour measurement and oncology response assessment at scale.
H&E and IHC tissue analysis for endpoints.
Oncology under one accountable platform. From scan to slide.
Our clinical and technical team will walk you through how GenPhase compares to your current imaging setup - and what the transition looks like.
1990 N California Blvd., 8th Floor
Walnut Creek, CA 94596
(844) 922-7468
hello@genphase.ai
Fill out the form and our team will reach out within 24 hours to schedule your call.
By submitting this form, you agree to let GenPhase use the information provided to send relevant content about our services. You can unsubscribe at any time.
